Open research questions in Psychedelics and Drug Studies
305 unresolved questions extracted from the limitations and future-work sections of 1,073 Psychedelics and Drug Studies papers in our library. Each links back to the study that raised it.
What the literature leaves open
the presence of psychological support as part of psilocybin dosing complicates eventual licensing - the intensity of acute psychological effects of psilocybin can cause anxiety and distress during the dosing day - the need for high-quality evidence on the components of psychological support required for psilocybin treatment
Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin · 2026 · DOICurrent data and reporting are not sufficient for analysis, - Lack of mechanistic studies, - Limited understanding of the exact role of psychological support
Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin · 2026 · DOIThe challenge of addressing the methodological limitations of current studies, including small samples, functional unblinding, and limited long-term follow-up. The challenge of developing a regulated ecosystem for the clinical translation of psychedelics, including product standards, service standards, patient safeguards, and reimbursement arrangements. The challenge of balancing enthusiasm and fear in public discourse, moving beyond polarized narratives and excessive enthusiasm or fear.
Small samples, - Functional unblinding, - Expectancy effects, - Heterogeneous psychological support, - Limited long-term follow-up on safety and efficacy
The paper identifies the challenge of providing spiritual and emotional support to patients in psychedelic assisted therapies, given the lack of training in spirituality and religion among interprofessional practitioners. It also highlights the challenge of developing competencies for chaplains to provide high-quality care in this context. The paper notes the controversy surrounding the requirement for PAT providers to have had their own psychedelic experiences.
The paper identifies a lack of training in spirituality and religion among interprofessional practitioners in psychedelic assisted therapies. It also highlights the need for chaplains to pursue specialized education and supervised experience beyond their standard professional requirements.
There is a lack of understanding of the attitudes of law enforcement and military personnel towards psychedelic-assisted psychotherapy. The study aims to fill this gap by investigating the current views and perspectives of these groups.
Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel · 2026 · DOIThe paper identifies the challenge of understanding the complex and diverse nature of metaphysical healing practices. The paper highlights the need to analyze the cultural and social contexts in which these practices are situated. The paper discusses the challenge of reconciling individual health-seeking with government obligations to public health.
The paper identifies a gap in the understanding of the mind-cure movement and its connections to metaphysical healing practices. The paper highlights the need for further analysis of the distinction between shamanic practices that are learned and those that are inherited.
Investigating the long-term effects of psychedelic use on mental health, - Examining the relationship between psychedelic use and PTSD symptoms in a larger, more representative sample, - Developing effective interventions for individuals experiencing PTSD symptoms after psychedelic use
Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study · 2026 · DOIPrior studies have primarily focused on assessing a broad set of psychopathological symptoms without employing a classificatory diagnostic approach. There is a lack of research on the relationship between psychedelic use and PTSD symptoms using a diagnostic approach.
Post-traumatic stress disorder symptoms following psychedelic use: a naturalistic survey study · 2026 · DOIThe complexity of causal relationships in psychiatric disorders makes treatment challenging. The non-linear causal dynamics of psychiatric disorders are difficult to address. The paper identifies the need to integrate biological and environmental factors in mental health as a challenge.
Permissive and instructive causality: integrating biological and environmental factors in mental health · 2026 · DOIThe need to balance the therapeutic potential of psilocybin with its hallucinogenic activity. The challenge of identifying a subperceptual dose of psilocybin that can be safely administered without in-clinic supervision. The difficulty of measuring the effects of low-dose psilocybin on psychophysiological responses, cognitive performance, and state anxiety.
A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults · 2026 · DOIInvestigate the effects of psilocybin on patients with psychiatric disorders. Examine the long-term effects of psilocybin administration. Explore the potential therapeutic applications of sub-hallucinogenic psilocybin doses.
A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults · 2026 · DOIThe challenge of understanding the complex effects of psychedelic compounds on the brain and behavior. The difficulty of translating findings from animal models to humans. The need to develop effective and safe therapeutic protocols using psilocybin and ethocybin.
Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice · 2026 · DOIInvestigate the effects of PSY and ETH in female mice, - Investigate the long-term effects of PSY and ETH, - Examine the potential therapeutic benefits of PSY and ETH for stress-related psychiatric disorders
Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male mice · 2026 · DOIhead-to-head trials of PAT, with different randomized conditions corresponding with differing theoretical orientations or differing quantities of psychotherapy, - survey patients and consumers who are potentially interested in PAT
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy · 2025 · DOIThere is limited evidence regarding the interaction of the modality of psychotherapy on the clinical impact of psychedelic-assisted therapy. The type of therapy that should be employed in psychedelic-assisted therapy is unclear. The paper identifies a gap in the research on the role of psychotherapy in psychedelic-assisted therapy.
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy · 2025 · DOIFuture research should further validate the PAEQ and explore causal mechanisms using longitudinal and experimental designs - Future research should focus on refining and validating the scale and its factor structure
Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes · 2025 · DOIInvestigating the effects of psychedelic use in controlled settings, - Examining the relationship between psychedelic use and psychiatric history, - Studying the impact of psychedelic use on vulnerable populations
Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms · 2025 · DOILess is known about the risks associated with psychedelic use outside of medically supervised contexts. Prior studies have primarily focused on the effects of psychedelics in controlled settings, excluding populations that are typically vulnerable to adverse effects.
Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms · 2025 · DOIEnsuring the safety and well-being of patients in psychedelic therapy is a fundamental ethical concern. The intense nature of the experiences facilitated by psychedelics causes additional risks and requires clear guidelines regarding professional ethics. Equity and access concerns are paramount in ensuring that vulnerable populations are not 'left behind' in the current and future provision of psychedelic-assisted therapies.
Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review · 2025 · DOIThe challenge of treating music as an active variable whose inclusion requires empirical justification. The challenge of designing clinically testable questions and randomized trials to inform more effective treatment models. The challenge of balancing the need for a supportive therapeutic environment with the risk of introducing external emotional content that may obscure the patient's natural psychological flow.
Clinically testable questions, such as whether music fosters emotional insight or deflects it, - Randomized trials, and neurophenomenological studies, and long-term follow-ups comparing different settings could clarify whether music enhances or interferes with therapeutic goals
There is a lack of qualitative studies examining the subjective effects of psychedelic use in people with a history of non-affective psychotic disorders. Prior studies have explored the impact of naturalistic psychedelic use on people with a history of psychotic disorders, but have not used semi-structured interviews to examine subjective effects.
How do psychedelics impact people with a history of non-affective psychosis? A qualitative study · 2025 · DOI
Most-cited papers in Psychedelics and Drug Studies
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer · Archives of General Psychiatry · 2010 · 1,056 citations
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial · Psychological Medicine · 2018 · 688 citations
- Long-term follow-up of psilocybin-facilitated smoking cessation · The American Journal of Drug and Alcohol Abuse · 2016 · 562 citations
- Psychedelics and Psychedelic-Assisted Psychotherapy · American Journal of Psychiatry · 2020 · 546 citations
- Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors · Science · 2023 · 492 citations
- Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up · Journal of Psychopharmacology · 2022 · 379 citations
- Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin · Journal for the Scientific Study of Religion · 2012 · 349 citations
- Decreased Brain GABAA-Benzodiazepine Receptor Binding in Panic Disorder · Archives of General Psychiatry · 1998 · 304 citations
- Structure-based discovery of nonhallucinogenic psychedelic analogs · Science · 2022 · 298 citations
- Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies · Acta Psychiatrica Scandinavica · 2020 · 284 citations
Most recent work
- An international mega-analysis of psychedelic drug effects on brain circuit function · Nature Medicine · 2026
- The science of psychedelic medicine · Nature Medicine · 2026
- A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial · Nature Medicine · 2026
- Psilocybin or Nicotine Patch for Smoking Cessation · JAMA Network Open · 2026
- Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy · JAMA Network Open · 2026
- Ayahuasca Groups and Networks in the Netherlands: A Challenge to the Study of Contemporary Religion · UvA-DARE (University of Amsterdam) · 2026
- Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization · Frontiers in Psychiatry · 2026
- Neural signaling mechanisms in depression: bridging classical monoamine hypotheses, animal models, and emerging antidepressant strategies · Frontiers in Cell and Developmental Biology · 2026
- Psilocybin in the Treatment of Cocaine Use Disorder · JAMA Network Open · 2026
- Suggestibility and psychedelics: From therapeutics to social context. · Psychology of Consciousness: Theory, Research, and Practice · 2026
Find a gap in your own Psychedelics and Drug Studies sub-topic
This page shows what the Psychedelics and Drug Studies literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →